๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cervical Cancers
Clinical trial register · China

Cervical Cancers Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Shanghai 3 Chongqing 2 Guangzhou 2 Hefei 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Shanghai3 Chongqing2 Guangzhou2 Hefei1
All 11 locations
Target enrolment
to

Cervical Cancers trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NCT07684508Hypofractionated Radiotherapy, Intensity-modulated Radiotherapy, Cervical Cancers
Manni Huang
Not applicable
154
Beijing, Langfang
2026-07-10
Recruiting
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
NCT07130240Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-08-15
Recruiting
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
NCT07003620Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
34
Guangzhou
2025-06-29
Recruiting
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
NCT06878222Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
35
Shanghai
2025-03-15
Not yet open
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
NCT06724263Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers, Small Cell Lung Cancer
DrugB1962
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
120
Shanghai
2024-12
Recruiting
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
NCT06727617Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital
Phase 2
134
Tianjin
2024-11-19
Active, closed
Toripalimab for High-risk Locally Advanced Cervical Cancer
NCT06416696Cervical Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
57
Beijing
2024-01-09
Recruiting
The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
NCT06349148Cervical Cancers
SHUANG ZHENG JIA, PhD
Not applicable
50
Beijing
2024-01-01
Recruiting
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
NCT06799637Advanced Solid Tumors, Pancreatic Carcinoma, Ovarian Cancer, Cervical Cancers
Evopoint Biosciences Inc.
Phase 1/2
350
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Guiyang, Baoding, Harbin
2023-12-01
By invitation
Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids
NCT06786780Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers
Chongqing University Cancer Hospital
Phase 2
50
Chongqing
2023-01-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/cervical-cancers

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Cervical Cancers.

How many Cervical Cancers trials are recruiting in China?

7 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cervical Cancers), 10 studies
PhaseStudiesRecruitingShare
Phase 27470%
Not applicable2220%
Phase 1/21110%

Most active sponsors

Lead sponsors with the most studies (Cervical Cancers)
Lead sponsorStudiesRecruiting
Obstetrics & Gynecology Hospital of Fudan University22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10
Chongqing University Cancer Hospital10
Evopoint Biosciences Inc.11
Manni Huang11
SHUANG ZHENG JIA, PhD11
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Tasly Biopharmaceuticals Co., Ltd.10
Tianjin Medical University Cancer Institute and Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.